Flufenoximacil is a novel oral antibiotic belonging to the oxadiazole class, primarily indicated for the treatment of severe bacterial infections, including those caused by methicillin-resistant Staphylococcus… Read more
Flufenoximacil is a novel oral antibiotic belonging to the oxadiazole class, primarily indicated for the treatment of severe bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae, by inhibiting cell wall synthesis and disrupting membrane integrity. To support the rigorous analytical demands of pharmaceutical development, this category includes essential tools for comprehensive quality control. Researchers and analytical chemists utilize these high-purity reference standards, process-related impurities, and metabolic degradation products to facilitate accurate impurity profiling and method validation. Furthermore, the inclusion of stable isotope labelled compounds allows for precise quantification in complex biological matrices, ensuring high-precision analytical testing throughout the drug development lifecycle. By providing a reliable source for these critical analytical markers, laboratories can effectively monitor the purity and stability of the active pharmaceutical ingredient against regulatory standards.